ArticleJournal of clinical and experimental hematopathology : JCEH2025
The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience.
Noriyoshi Iriyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.